Stock Chart

RYTM

$89.55 +1.05%
Score: 70.2 HOLD
Pro
Screener
Vol: 0.28x (vs SPY: 0.4x | vs QQQ: 0.2x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 22, 2026
Falling Channel Bullish scenario quality 61/100
Measured-move target $95.53 (+6.7%)
Historically breaks up 64% of the time; target hit in 60% of up-breaks (n=559)
Pattern detection is automated and probabilistic — a scenario map for levels, not a buy/sell signal. Rails, projected path and target are drawn on the chart below.
Technical Chart
OVERLAYS
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER
SETTINGS
Active (2)
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About RYTM - Rhythm Pharmaceuticals, Inc. Common Stock

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Key Statistics

Market Cap $6B

More RYTM Analysis

Buy or Sell Analysis Price Prediction AI Analysis Fair Price Options Advisor Trendline Analysis

This RYTM stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track RYTM's price movements with trendlines, gamma walls, and key support/resistance levels.